Sycal Ventures Berhad (KLSE:SYCAL)

Market Cap	68.69M
Revenue (ttm)	30.57M
Net Income (ttm)	447.00K
Shares Out	416.32M
EPS (ttm)	0.00
PE Ratio	153.20
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,900
Average Volume	35,710
Open	0.1650
Previous Close	0.1750
Day's Range	0.1650 - 0.1800
52-Week Range	0.1400 - 0.2350
Beta	0.36
RSI	41.86
Earnings Date	Aug 29, 2025

About Revance Therapeutics

Sycal Ventures Berhad, an investment holding company, operates as a contractor for building, infrastructure, and civil construction works in Malaysia. It operates in three segments: Construction, Property Development and Management, and Manufacturing and Trading. The company invests in and develops properties; and provides property management and consultancy services; as well as operates a theme park and convention hall facilities. In addition, it manufactures, supplies, and trades in ready-mix concrete; and trades in building materials; as wel...

• Industry: General Building Contractors-nonresidential
• Founded: 1980
• Country: Malaysia
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SYCAL

Financial Performance

In 2024, Sycal Ventures Berhad's revenue was 76.81 million, an increase of 6.33% compared to the previous year's 72.24 million. Earnings were 1.91 million, an increase of 15.98%.